SpaceX (SPCX) Analysis: UBS Buy Rating Amid AI Investment

Font: Financial Modeling Prep  • Aug 05, 2026

SpaceX (NASDAQ: SPCX) Stock Analysis: Analyst Confidence Amid Market Volatility and Heavy AI Investment

• UBS maintained a Buy rating on SpaceX (NASDAQ: SPCX), signaling continued analyst confidence despite recent market volatility.
• SpaceX’s stock declined after the company’s first earnings report as investors reacted to a significant increase in capital expenditures, primarily related to AI infrastructure.
• Despite the sell-off, SpaceX reported approximately 92% year-over-year revenue growth and a smaller-than-expected net loss, supported by AI cloud agreements and continued Starlink expansion.

On August 5, 2026, UBS maintained its Buy rating on SpaceX (NASDAQ: SPCX). SpaceX develops rockets and spacecraft and operates the Starlink satellite-internet service. The rating was reiterated while the stock was trading at approximately $115.42, signaling continued analyst confidence despite market volatility.

This positive analyst view contrasted with the market’s reaction to SpaceX’s first quarterly earnings report as a public company. The company’s shares fell approximately 10% after the results and traded near $113.27, below the $135.00 IPO price established after its record-breaking June debut.

The stock decline followed news that capital expenditures had increased more than sixfold to approximately $18.40 billion in the second quarter. Capital expenditures are funds a company uses to purchase or develop long-term assets. Most of SpaceX’s spending was directed toward AI infrastructure, including data centers and computing capacity.

The heavy spending overshadowed an otherwise strong quarter. SpaceX reported revenue of approximately $7.8 billion, representing year-over-year growth of about 92%. The increase was driven by AI cloud agreements, higher AI-related revenue, and continued expansion of its Starlink satellite-internet business.

The company also reported a net loss of approximately $541 million, or $0.09 per share. This was smaller than analysts had expected. Strong revenue growth and a better-than-expected loss likely supported UBS’s positive view, although the company’s substantial AI spending remains a significant risk for investors.